Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy: (90)Y Radioembolization for BCLM

PURPOSE: The purpose of this open-label, retrospective report was to determine the safety and effectiveness of locoregional therapy with yttrium-90 ((90)Y) radioembolization for patients with progressing breast cancer liver metastases (BCLM) despite polychemotherapy. MATERIALS & METHODS: Seventy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Vasc Interv Radiol
Autors principals: Gordon, Andrew C., Gradishar, William J., Kaklamani, Virginia G., Thuluvath, Avesh J., Ryu, Robert K., Sato, Kent T., Gates, Vanessa L., Salem, Riad, Lewandowski, Robert J.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720166/
https://ncbi.nlm.nih.gov/pubmed/25156827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2014.07.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars